| NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. Co. designs, builds and markets medical devices that stimulate nerves and analyzes nerve response for diagnostic and therapeutic purposes. Co.'s products consist of a medical device used in conjunction with a consumable electrode or biosensor. Co.'s marketed products include: DPNCheck, which is a nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy; Quell, which is a wearable device for symptomatic relief of chronic pain; and ADVANCE System, which is a platform for the performance of nerve conduction studies. The NURO YTD return is shown above.
The YTD Return on the NURO YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether NURO YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the NURO YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.